Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Australas J Dermatol ; 64(3): 330-338, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37408523

RESUMEN

BACKGROUND: Alopecia areata (AA) is a common immune-mediated non-scarring hair loss, with a worldwide incidence between 0.57% and 3.8%. The incidence and prevalence of AA in the Australian general population have not been previously reported. OBJECTIVE: To describe the incidence and prevalence of AA in Australia using primary care data. A secondary objective was to identify common demographic characteristics, comorbidities and treatment patterns among Australians living with AA. METHODS: We analysed electronic health record data captured from a national clinical practice management software over a 10-year index period between 2011 and 2020 calendar years, inclusive. The incidence of new-onset AA and the prevalence of active records with AA were estimated. Differences in incidence by sociodemographic groups, and patterns of treatment were also evaluated. RESULTS: There were 976 incident AA records. The incidence of new-onset AA in the total study cohort was 0.278 per 1000 person-years (95% CI 0.26-0.295). By age, the incidence was highest in the 19- to 34-year-old age bracket (0.503 per 1000 person-years: 95% CI 0.453-0.554). AA incidence was lower among females than males (IRR 0.763, p < 0.001, 95% CI 0.673-0.865). Among active records, 520 were prevalent AA records. AA point prevalence at 31/12/2020 was 0.13% (1.26 per 1000 persons; 95% CI 1.15-1.37). CONCLUSION: This is the first study to describe the epidemiology (incidence and point prevalence) and management of AA in the Australian primary health-care population through large-scale database analysis. Incidence and prevalence findings were consistent with earlier estimates from other regions.


Asunto(s)
Alopecia Areata , Masculino , Femenino , Humanos , Adulto Joven , Adulto , Alopecia Areata/epidemiología , Alopecia Areata/tratamiento farmacológico , Estudios Retrospectivos , Prevalencia , Incidencia , Registros Electrónicos de Salud , Australia/epidemiología , Atención Primaria de Salud
2.
Pediatr Transplant ; 27(2): e14467, 2023 03.
Artículo en Inglés | MEDLINE | ID: mdl-36604853

RESUMEN

BACKGROUND: In order to improve transparency within the patient selection process, a transplant listing advisory committee was formed within the Boston Children's Hospital Pediatric Transplant Center. Its mission is to promote equity in access to organ transplantation by ensuring that the institutional transplant selection criteria are fair, unbiased, and nondiscriminatory. The committee conducts comprehensive case and data review of individual characteristics and reviews in aggregate to identify potential systems bias. METHODS: Charts for 256 patients evaluated for transplant from 3/2016 to 3/2019 were reviewed. Among these, 64 (25%) patients were declined for transplant. Univariate logistic regression analysis was used to identify demographic variables and vulnerable status factors associated with being declined. Odds ratios (OR) are reported. RESULTS: Among all patients, median age was 8.5 years and 58% were male. Asian patients were more likely to be declined than White patients (OR = 5.3, Wald p = .007). Socioeconomic factors that affected likelihood of listing decline included concerns for caregivers' ability to manage and understand care requirements (OR = 3.8, p = .011), caregiver employment status (OR = 1.9, p = .042), and use of public assistance programs (OR = 2.2, p = .05). Patients with severe neurodevelopmental delay were more likely to be declined for listing (OR = 3.7, p = .019). CONCLUSION: This analysis identified areas of potential bias related to race, socioeconomic status, and neurodevelopmental delay where initiatives can be targeted. Advisory committees are an important aspect of evaluating equity in transplant center selection policy and practice.


Asunto(s)
Trasplante de Órganos , Listas de Espera , Humanos , Masculino , Niño , Femenino , Factores Socioeconómicos , Clase Social , Empleo
3.
J Pediatr Gastroenterol Nutr ; 68(4): 472-479, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-30720563

RESUMEN

OBJECTIVE: The aim of the study was to investigate the impact of prioritizing infants, children, adolescents, and the sickest adults (Status 1) for deceased donor livers. We compared outcomes under two "SharePeds" allocation schema, which prioritize children and Status 1 adults for national sharing and enhanced access to pediatric donors or all donors younger than 35 years, to outcomes under the allocation plan approved by the Organ Procurement and Transplant Network in December 2017 (Organ Procurement and Transplantation Network [OPTN] 12-2017). METHODS: The 2017 Liver Simulated Allocation Model and Scientific Registry of Transplant Recipients data on all US liver transplant candidates and liver offers 7/2013 to 6/2016 were used to predict waitlist deaths, transplants, and post-transplant deaths under the OPTN 12-2017 and SharePeds schema. RESULTS: Prioritizing national sharing of pediatric donor livers with children (SharePeds 1) would decrease waitlist deaths for infants (<2 years, P = 0.0003) and children (2-11 years, P = 0.001), with no significant change for adults (P = 0.13). Prioritizing national sharing of all younger than 35-year-old deceased donor livers with children and Status 1A adults (SharePeds 2) would decrease waitlist deaths for infants, children, and all Status 1A/B patients (P < 0.0001 for each). SharePeds 1 and 2 would increase the number of liver transplants done in infants, children, and adolescents compared to the OPTN-2017 schema (P < 0.00005 for all age groups). Both SharePeds schema would increase the percentage of pediatric livers transplanted into pediatric recipients. CONCLUSIONS: Waitlist deaths could be significantly decreased, and liver transplants increased, for children and the sickest adults, by prioritizing children for pediatric livers and with broader national sharing of deceased donor livers.


Asunto(s)
Trasplante de Hígado , Modelos Teóricos , Obtención de Tejidos y Órganos , Listas de Espera , Adolescente , Niño , Preescolar , Humanos , Estados Unidos
4.
Pediatr Transplant ; 20(5): 647-51, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27239056

RESUMEN

Routine use of transanastomotic biliary stents (RTBS) for biliary reconstruction in liver transplantation (LT) is controversial, with conflicting outcomes in adult randomized trials. Pediatric literature contains limited data. This study is a retrospective review of 99 patients who underwent first LT (2005-2014). In 2011, RTBS was discontinued at our center. This study describes biliary complications following LT with and without RTBS. 56 (56%) patients had RTBS. Median age at LT was 1.9 yr (IQR 0.7, 8.6); 55% were female. Most common indication for LT was biliary atresia (36%). Most common biliary reconstruction was Roux-en-Y choledochojejunostomy (75% with RTBS, 58% without RTBS, p = 0.09). Biliary complications (strictures, bile leaks, surgical revision) occurred in 23% without significant difference between groups (20% with RTBS, 28% without RTBS, p = 0.33). Patients with RTBS had routine cholangiography via the tube at 6-8 wk; thus, significantly more patients with RTBS had cholangiograms (91% vs. 19%, p < 0.0001). There was no difference in the number of patients who required therapeutic intervention via endoscopic or percutaneous transhepatic cholangiography (11% with RTBS, 19% no RTBS, p = 0.26). Routine use of RTBS for biliary reconstruction in pediatric LT may not be necessary, and possibly associated with need for costlier, invasive imaging without improvement in outcomes.


Asunto(s)
Coledocostomía/instrumentación , Trasplante de Hígado/métodos , Complicaciones Posoperatorias/prevención & control , Stents , Adolescente , Niño , Preescolar , Femenino , Estudios de Seguimiento , Humanos , Lactante , Recién Nacido , Masculino , Complicaciones Posoperatorias/diagnóstico por imagen , Complicaciones Posoperatorias/epidemiología , Complicaciones Posoperatorias/etiología , Estudios Retrospectivos , Resultado del Tratamiento
5.
Pediatr Transplant ; 19(2): E41-6, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25516432

RESUMEN

We present a case of a three-yr-old child with a history of multisystem Langerhans cell histiocytosis treated with systemic chemotherapy, who developed progressive liver failure and received an orthotopic split liver transplant while continuing on chemotherapy. One month following transplant, he developed acute graft-vs.-host disease of the skin and gastrointestinal tract. Peripheral blood chimerism studies post-transplant demonstrated an increasing predominance of donor lymphocytes and granulocytes. Shortly after, the patient developed vitiligo, and two yr after transplantation, the patient developed skin manifestations of psoriasis. We discuss and review the current literature, which demonstrates that chimerism following liver transplantation is rare and in our patient may be related to his profound immunosuppression around the time of liver transplant as well the development of acute graft-versus-host disease. While autoimmune disease can occur after solid organ and stem cell transplant, our patient developed skin manifestations of autoimmunity after liver transplantation, which is also rarely described.


Asunto(s)
Médula Ósea/patología , Enfermedad Injerto contra Huésped , Trasplante de Hígado/efectos adversos , Enfermedades de la Piel/fisiopatología , Autoinmunidad , Biopsia , Preescolar , Tracto Gastrointestinal/fisiopatología , Granulocitos/citología , Histiocitosis/fisiopatología , Humanos , Trasplante de Hígado/métodos , Linfocitos/citología , Masculino , Complicaciones Posoperatorias , Psoriasis/complicaciones , Psoriasis/fisiopatología , Quimera por Trasplante , Vitíligo/complicaciones , Vitíligo/fisiopatología
6.
J Pediatr Surg ; 49(1): 104-7; discussion 108, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-24439591

RESUMEN

BACKGROUND: Since its introduction as an alternative intestinal lengthening technique, serial transverse enteroplasty (STEP) has been increasingly used as the surgical treatment of choice for patients with refractory short bowel syndrome (SBS). While primary STEP for the treatment of congenital conditions was proposed in the original description of the procedure, emphasis was placed on a delayed or staged approach to these patients. To date, a comprehensive review of the outcomes from this sub-population has not been reported by the International STEP Data Registry. METHODS: A retrospective review of the International STEP Data Registry was performed to identify all patients who underwent STEP as a primary operative procedure for the treatment of congenital SBS. Changes in pre- and post-STEP values were assessed using paired t-tests with significance set at p<0.05. Data are presented as mean ± standard deviation. RESULTS: Fifteen patients underwent primary STEP for congenital SBS between September 1, 2004, and April 10, 2012. Thirteen patients had follow-up information available. Causes of congenital SBS included closing gastroschisis, small bowel atresia, and midgut volvulus. Twelve patients had pre- and post-STEP bowel measurements taken. Average pre- and post-STEP bowel lengths were 32 ± 16 cm and 47 ± 22 cm, respectively. Intestinal length was increased by a mean of 15 ± 12 cm for a relative small bowel length increase of 50.4 ± 27.3% (p<0.001). Only one patient required an ostomy at the time of primary STEP. A second patient required a temporary ostomy at 3months of age that was later closed. There was one death from intestinal failure associated liver disease (IFALD). Another patient experienced IFALD progression and required liver and intestinal transplantation. The most commonly reported complication following primary STEP was obstruction or bowel re-dilatation requiring additional operative interventions. Nine patients underwent second STEP procedures under these circumstances. Eight patients remain dependent on parenteral nutrition, while three patients achieved enteral autonomy. CONCLUSIONS: Primary STEP is a feasible and safe surgical option for the treatment of congenital conditions resulting in SBS. Primary STEP establishes early bowel continuity, creates intestinal length from congenitally dilated bowel, and appears to obviate the need for interval stomas and their associated loss of bowel length in neonates with congenital SBS. However, with recent changes in SBS management emphasizing intestinal rehabilitation, additional studies are needed to assess the long-term impact on intestinal adaptation of STEP performed in the neonatal period prior to adoption of this technique.


Asunto(s)
Intestino Delgado/anomalías , Intestino Delgado/cirugía , Síndrome del Intestino Corto/cirugía , Expansión de Tejido/métodos , Estudios de Seguimiento , Gastrosquisis/complicaciones , Edad Gestacional , Humanos , Recién Nacido , Atresia Intestinal/complicaciones , Vólvulo Intestinal/complicaciones , Fallo Hepático/epidemiología , Fallo Hepático/cirugía , Trasplante de Hígado , Estomía/estadística & datos numéricos , Nutrición Parenteral/estadística & datos numéricos , Complicaciones Posoperatorias/epidemiología , Sistema de Registros , Estudios Retrospectivos , Síndrome del Intestino Corto/etiología , Resultado del Tratamiento
7.
J Pediatr Surg ; 48(7): 1584-7, 2013 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-23895976

RESUMEN

Traumatic injury has been the most common cause of morbidity and mortality in the pediatric population, but injuries to the abdominal aorta are rare. We reviewed 2 children who underwent exploratory laparotomy for blunt aortic injury in which intra-operative ultrasound guided the surgical approach. Intra-operative ultrasound allowed us to minimize resection of normal aorta and achieve primary repair. In the pediatric population, achieving primary repair is ideal, as synthetic grafts will likely need future revisions as children grow. Here we present the use of intra-operative ultrasound in maximizing the chance at primary repair of the aorta following blunt injury.


Asunto(s)
Traumatismos Abdominales/diagnóstico por imagen , Traumatismos Abdominales/cirugía , Técnicas de Apoyo para la Decisión , Cuidados Intraoperatorios/métodos , Ultrasonografía Intervencional , Heridas no Penetrantes/diagnóstico por imagen , Heridas no Penetrantes/cirugía , Adolescente , Humanos , Masculino
8.
Pediatr Nephrol ; 28(10): 2023-33, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23775038

RESUMEN

BACKGROUND: Midaortic syndrome is often associated with refractory hypertension. The aim of our study was to better understand the short- and medium-term outcomes in this patient population utilizing a multidisciplinary management approach. METHODS: We conducted a review of patients with midaortic syndrome treated at our institution over the past 30 years. RESULTS: Fifty-three patients presented at a median age of 6.7 years (birth to 28.7 years). Thirty-five patients (66 %) underwent invasive management (percutaneous techniques: 21; surgical techniques: 5; both: 9). Percutaneous interventions were acutely successful in decreasing the gradient across the obstruction and degree of luminal stenosis. However, freedom from reintervention was 58 % at 1 year and 33 % at 5 years. Freedom from reintervention after a surgical procedure was longer: 83 % at 1 year and 72 % at 10 years. At the most recent follow-up, the majority of patients (69 %) were normotensive. The median duration between time of presentation and achievement of blood pressure control was 5.7 (0.4-21.1) years. The median number of anti-hypertensive medications was 1 (0-5). CONCLUSIONS: A multidisciplinary management strategy which couples comprehensive medical management with catheter-based and surgical interventions can lead to adequate blood pressure control and preservation of end-organ function in patients with midaortic syndrome.


Asunto(s)
Antihipertensivos/uso terapéutico , Aorta Abdominal/efectos de los fármacos , Aorta Abdominal/cirugía , Enfermedades de la Aorta/terapia , Arteriopatías Oclusivas/terapia , Procedimientos Endovasculares , Hipertensión/terapia , Procedimientos Quirúrgicos Vasculares , Adolescente , Adulto , Antihipertensivos/efectos adversos , Aorta Abdominal/fisiopatología , Enfermedades de la Aorta/diagnóstico , Enfermedades de la Aorta/tratamiento farmacológico , Enfermedades de la Aorta/fisiopatología , Enfermedades de la Aorta/cirugía , Arteriopatías Oclusivas/diagnóstico , Arteriopatías Oclusivas/tratamiento farmacológico , Arteriopatías Oclusivas/fisiopatología , Arteriopatías Oclusivas/cirugía , Presión Arterial/efectos de los fármacos , Boston , Niño , Preescolar , Terapia Combinada , Constricción Patológica , Procedimientos Endovasculares/efectos adversos , Femenino , Humanos , Hipertensión/diagnóstico , Hipertensión/tratamiento farmacológico , Hipertensión/fisiopatología , Hipertensión/cirugía , Lactante , Recién Nacido , Estimación de Kaplan-Meier , Masculino , Estudios Retrospectivos , Síndrome , Factores de Tiempo , Resultado del Tratamiento , Procedimientos Quirúrgicos Vasculares/efectos adversos , Adulto Joven
9.
Pediatr Transplant ; 16(7): E296-300, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22188489

RESUMEN

Clinical and pathologic studies on adults with uremic neuropathy are numerous, but less is known about this disorder in children and adolescents. We report the clinical, electrophysiologic, and pathologic findings in an adolescent female with uremic neuropathy. Electrophysiologic findings were consistent with a primarily axonal sensorimotor polyneuropathy. Sural nerve biopsy revealed areas of focal depletion in myelin sheaths and loss of axons. Axonal degeneration with secondary myelin changes appears to be the characteristic pathology in this case, one of the youngest to our knowledge for which nerve biopsy data are available. Our patient experienced dramatic recovery after renal transplantation, similar to the reports of older patients.


Asunto(s)
Glomeruloesclerosis Focal y Segmentaria/terapia , Trasplante de Riñón/métodos , Polineuropatías/terapia , Insuficiencia Renal/terapia , Uremia/terapia , Adolescente , Axones/patología , Biopsia/métodos , Femenino , Humanos , Conducción Nerviosa , Polineuropatías/etiología , Nervio Sural/patología , Resultado del Tratamiento
10.
Pediatr Transplant ; 15(7): E142-4, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20412506

RESUMEN

We report a case of a pediatric en bloc liver-double kidney transplant in a patient with IVC thrombosis below the renal veins. The patient is an 11-month-old girl diagnosed with congenital nephrotic syndrome at two months of age. Multifocal liver masses were identified on routine ultrasound at eight months of age. Alpha fetoprotein level was 55 319. Biopsy confirmed hepatoblastoma. CT scan confirmed multiple lesions in both lobes, which would require liver transplantation for resection. She was also found to have thrombosis of her infrarenal IVC secondary to multiple central lines. She was listed for combined liver-kidney transplant and began chemotherapy. After four cycles of chemotherapy, she underwent bilateral nephrectomies followed by a combined en bloc liver-double kidney transplant from a size matched donor. In order to provide adequate venous outflow from the kidneys in the absence of a recipient infrarenal IVC, the donor liver and kidneys were procured en bloc with a common arterial inflow via the infrarenal aorta and common outflow via the suprahepatic IVC. Kidney transplantation in the absence of adequate recipient venous drainage may require unusual vascular reconstruction techniques. This case demonstrates a novel approach in patients who may require combined liver-kidney transplantation.


Asunto(s)
Trasplante de Riñón/métodos , Trasplante de Hígado/métodos , Trombosis/patología , Vena Cava Inferior/fisiopatología , Aorta/patología , Conductos Biliares/cirugía , Biopsia/métodos , Femenino , Hepatoblastoma/patología , Hepatoblastoma/cirugía , Humanos , Lactante , Neoplasias Hepáticas/patología , Neoplasias Hepáticas/cirugía , Modelos Anatómicos , Vena Porta/cirugía , Tomografía Computarizada por Rayos X/métodos
11.
J Laparoendosc Adv Surg Tech A ; 19 Suppl 1: S249-54, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19371150

RESUMEN

BACKGROUND/PURPOSE: Aortopexy is an established treatment method for severe tracheomalacia. It can be performed by thoracotomy or thoracoscopically. The purpose of this study is to review our experience with thoracoscopic aortopexy. METHODS: Thoracoscopic aortopexy was performed for treatment of tracheomalacia in five patients. A left-sided approach with three ports was used. The aorta was sutured to the sternum with a series of transversely oriented simple interrupted Prolene sutures. Knots were tied subcutaneously. Pre- and postprocedure bronchoscopy was used to verify improvement in tracheal patency. The study protocol was approved by the Institutional Review Board. A retrospective chart review was performed and indications, perioperative course, and, where available, long-term results were noted. RESULTS: We treated four girls and one boy. Ages were between 6 weeks and 2 years. Weights were between 3.2 and 10 kg. Resolution of symptoms was achieved in all patients. There was no morbidity or mortality associated with the procedure. Length of hospital stay after aortopexy ranged between 4 and 59 days. Follow-up ranged between 34 and 5 months. CONCLUSIONS: Thoracoscopic aortopexy is an effective treatment for severe tracheomalacia not controlled by conservative measures. It can be safely performed even in small infants as long as equipment and skill for pediatric thoracoscopy are available. The authors believe that thoracoscopic exposure offers advantages over open technique and is cosmetically more pleasing to patients and their families. It may result in less pulmonary complications, shorter hospital stay, and less narcotic requirement compared to open thoracotomy.


Asunto(s)
Toracoscopía , Traqueomalacia/cirugía , Aorta/cirugía , Preescolar , Femenino , Estudios de Seguimiento , Humanos , Lactante , Masculino
12.
J Pediatr Surg ; 43(12): 2297-300, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19040959

RESUMEN

Focal nodular hyperplasia (FNH) is a benign, poorly understood hepatic tumor that is rare in children. Although there is no evidence for malignant degeneration, FNH can occur adjacent to a malignancy. Here, the case of a 4-year-old boy with a hepatic mass and history of stage IV neuroblastoma is presented. Initial imaging and core-needle biopsy were consistent with FNH. However, after left lateral segmentectomy, pathologic examination revealed a malignant tumor most consistent with small cell undifferentiated hepatoblastoma as well as 3 foci of FNH in the surrounding parenchyma.


Asunto(s)
Neoplasias de las Glándulas Suprarrenales , Hiperplasia Nodular Focal/etiología , Hepatoblastoma/diagnóstico , Neoplasias Hepáticas/diagnóstico , Neoplasias Primarias Secundarias/diagnóstico , Neuroblastoma , Neoplasias de las Glándulas Suprarrenales/tratamiento farmacológico , Neoplasias de las Glándulas Suprarrenales/radioterapia , Neoplasias de las Glándulas Suprarrenales/cirugía , Anticuerpos Monoclonales/uso terapéutico , Anticuerpos Monoclonales de Origen Murino , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Trasplante de Médula Ósea , Carboplatino/administración & dosificación , Preescolar , Cisplatino/administración & dosificación , Terapia Combinada , Ciclofosfamida/administración & dosificación , Etopósido/administración & dosificación , Fluorouracilo/administración & dosificación , Factor Estimulante de Colonias de Granulocitos/administración & dosificación , Hepatectomía , Hepatoblastoma/complicaciones , Hepatoblastoma/diagnóstico por imagen , Hepatoblastoma/tratamiento farmacológico , Hepatoblastoma/cirugía , Humanos , Ifosfamida/administración & dosificación , Inmunoglobulina G/uso terapéutico , Hallazgos Incidentales , Neoplasias Hepáticas/complicaciones , Neoplasias Hepáticas/diagnóstico por imagen , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/cirugía , Masculino , Melfalán/administración & dosificación , Mesna/administración & dosificación , Neoplasias Inducidas por Radiación/etiología , Neoplasias Primarias Secundarias/complicaciones , Neoplasias Primarias Secundarias/patología , Neuroblastoma/tratamiento farmacológico , Neuroblastoma/radioterapia , Neuroblastoma/cirugía , Radioterapia Adyuvante/efectos adversos , Tomografía Computarizada por Rayos X , Vincristina/administración & dosificación
13.
AIDS Res Hum Retroviruses ; 21(11): 961-4, 2005 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-16386114

RESUMEN

A patient who presented with late stage HIV-associated diseases could not be diagnosed by commercial ELISA tests and a Western blot. However, we could amplify proviral DNA of HIV-1. We found a novel GPGGMI motif in the V3 loop, a novel insertion of a proline in the C3 region, and persistent deletion of two amino acids in the vif gene. The patient had been treated with HAART after diagnosis. Forty months after the first amplification of HIV-1 DNA, anti-HIV-1 antibody was confirmed by ELISA and Western blot and, thus, we amplified and sequenced HIV-1 full sequences. Interestingly, the sequence at the TATAA box was TAAAA, although full sequences were not CRF01_AE. The major differences in the level of the HIV-1 gene between the seronegative and seropositive states were changes at the glycosylation site (NXT) next to the inserted proline and many resistance mutations including M184V to antiretroviral drugs occurred. This is the first report on HIV-1 full sequences isolated from seronegative AIDS patients infected with subtype B in Korea.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/virología , VIH-1/genética , VIH-1/aislamiento & purificación , TATA Box/genética , Síndrome de Inmunodeficiencia Adquirida/tratamiento farmacológico , Síndrome de Inmunodeficiencia Adquirida/inmunología , Adulto , Terapia Antirretroviral Altamente Activa , Western Blotting , Farmacorresistencia Viral/genética , Ensayo de Inmunoadsorción Enzimática , Genes vif , Glicosilación , Anticuerpos Anti-VIH/sangre , Proteína gp120 de Envoltorio del VIH/genética , Seropositividad para VIH , VIH-1/clasificación , Humanos , Corea (Geográfico) , Masculino , Datos de Secuencia Molecular , Provirus/genética , Provirus/aislamiento & purificación , Análisis de Secuencia de ADN , Eliminación de Secuencia
14.
J Pediatr Surg ; 39(3): 439-41; discussion 439-41, 2004 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15017566

RESUMEN

PURPOSE: Massive sacrococcygeal teratomas are typically resected and closed in a "chevron" fashion. The resultant scar may leave protuberant "dog ears" and extend across and below the infragluteal creases down onto the posterior thighs, causing undesirable buttock deformity. Given the redundant skin often available, the authors sought to develop a closure technique to minimize deformity and unpleasant scars. METHODS: At the time of resection of 2 sacrococcygeal teratomas, attention was directed to minimizing redundant skin, restoring normal buttock contour, and avoiding scars crossing the infragluteal crease. After properly securing the anal location, serial polygonal skin excisions were performed, working the excess tissue centrally rather than peripherally, leaving 2 right-angled scars on each buttock. RESULTS: Each infant underwent successful reconstruction with a normal buttock contour without redundancy. All scars on the buttocks can be easily covered by bathing attire. CONCLUSIONS: The excess skin expanded by large sacrococcygeal teratomas affords an opportunity to apply straightforward tissue rearrangement principles to reconstruct the buttocks with a normal contour and hidden scars.


Asunto(s)
Nalgas/cirugía , Procedimientos de Cirugía Plástica/métodos , Región Sacrococcígea/cirugía , Neoplasias de la Columna Vertebral/cirugía , Teratoma/cirugía , Cicatriz/prevención & control , Humanos , Lactante
15.
Chest ; 121(5): 1478-85, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-12006432

RESUMEN

BACKGROUND: The processes observed in interstitial lung disease are associated with the production, deposition, and proteolysis of the extracellular matrix (ECM), which may lead to irreversible pulmonary structural remodeling or to appropriate repair without fibrosis. Matrix metalloproteinases (MMPs) and a tissue inhibitor of metalloproteinases (TIMPs) are known to regulate remodeling of the ECM and thus to be important in the process of lung fibrosis. Pulmonary structures are extensively remodeled in usual interstitial pneumonia (UIP), whereas severe architectural remodeling is minimally present in cryptogenic organizing pneumonia (COP). However, not much is known about the roles of MMP-9 and/or TIMP-1 in COP. METHODS: Levels of MMP-9, TIMP-1 and the molar ratio of MMP-9/TIMP-1 in BAL fluids were investigated in 11 patients with UIP, in 8 patients with COP, and in 10 control subjects. We checked the levels of MMP-9 and TIMP-1 by means of enzyme immunoassay, and the hydrolytic activity of MMP-9 in BAL fluids was measured by gelatin zymography. Further, we evaluated the expression of MMP-9 and TIMP-1 in lung tissue by immunohistochemistry. RESULTS: The concentrations of MMP-9 and TIMP-1 were significantly increased in patients with UIP and were even higher in patients with COP compared with control subjects. The levels of MMP-9 and TIMP-1 were significantly higher in patients with COP than in patients with UIP. The molar ratio of MMP-9/TIMP-1 was significantly higher in patients with COP than in control subjects. In patients with COP, the concentration of MMP-9 significantly correlated with the number of neutrophils and lymphocytes. Zymographic analysis revealed that the activity of the 92-kd pro-MMP-9 was increased in patients with UIP and was even higher in patients with COP, compared with control subjects. CONCLUSIONS: These data suggest that overproduction of MMP-9 and TIMP-1, and an imbalance between MMP-9 and TIMP-1, may have a role as diagnostic references in COP.


Asunto(s)
Neumonía en Organización Criptogénica/metabolismo , Metaloproteinasa 9 de la Matriz/análisis , Inhibidor Tisular de Metaloproteinasa-1/análisis , Líquido del Lavado Bronquioalveolar/química , Líquido del Lavado Bronquioalveolar/citología , Recuento de Células , Neumonía en Organización Criptogénica/patología , Neumonía en Organización Criptogénica/fisiopatología , Femenino , Volumen Espiratorio Forzado , Humanos , Inmunohistoquímica , Pulmón/química , Enfermedades Pulmonares Intersticiales/metabolismo , Enfermedades Pulmonares Intersticiales/patología , Enfermedades Pulmonares Intersticiales/fisiopatología , Linfocitos , Masculino , Metaloproteinasa 9 de la Matriz/fisiología , Persona de Mediana Edad , Neutrófilos , Capacidad de Difusión Pulmonar , Inhibidor Tisular de Metaloproteinasa-1/fisiología , Capacidad Pulmonar Total , Capacidad Vital
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...